Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
818 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Loop Capital Maintains Buy on TD Synnex, Raises Price Target to $165

By vishwanath@benzinga.com
Today, 10:36 AM
Loop Capital analyst Ananda Baruah maintains TD Synnex (NYSE:SNX) with a Buy and raises the price target from $150 to $165.

SNX

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Cowen & Co. Maintains Outperform on Foot Locker, Lowers Price Target to $61

By vishwanath@benzinga.com
Today, 10:36 AM
Cowen & Co. analyst John Kernan maintains Foot Locker (NYSE:FL) with a Outperform and lowers the price target from $82 to $61.

FL

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Piper Sandler Maintains Overweight on Goosehead Insurance, Raises Price Target to $160

By vishwanath@benzinga.com
Today, 10:36 AM
Piper Sandler analyst Paul Newsome maintains Goosehead Insurance (NASDAQ:GSHD) with a Overweight and raises the price target from $155 to $160.

GSHD

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Piper Sandler Maintains Neutral on Discover Financial, Raises Price Target to $117

By vishwanath@benzinga.com
Today, 10:36 AM
Piper Sandler analyst Kevin Barker maintains Discover Financial (NYSE:DFS) with a Neutral and raises the price target from $114 to $117.

DFS

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Piper Sandler Maintains Overweight on Capital One Financial, Raises Price Target to $188

By vishwanath@benzinga.com
Today, 10:36 AM
Piper Sandler analyst Kevin Barker maintains Capital One Financial (NYSE:COF) with a Overweight and raises the price target from $177 to $188.

COF

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Piper Sandler Maintains Overweight on Biohaven Pharma Hldgs, Raises Price Target to $156

By vishwanath@benzinga.com
Today, 10:36 AM
Piper Sandler analyst Christopher Raymond maintains Biohaven Pharma Hldgs (NYSE:BHVN) with a Overweight and raises the price target from $140 to $156.

BHVN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Roth Capital Maintains Buy on Evolution Petroleum, Raises Price Target to $7.8

By vishwanath@benzinga.com
Today, 10:36 AM
Roth Capital analyst John White maintains Evolution Petroleum (AMEX:EPM) with a Buy and raises the price target from $6 to $7.8.

EPM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Buy on Post Holdings, Lowers Price Target to $128

By vishwanath@benzinga.com
Today, 10:36 AM
Citigroup analyst Wendy Nicholson maintains Post Holdings (NYSE:POST) with a Buy and lowers the price target from $134 to $128.

POST

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Buy on Duckhorn Portfolio, Raises Price Target to $28

By vishwanath@benzinga.com
Today, 10:36 AM
Citigroup analyst Wendy Nicholson maintains Duckhorn Portfolio (NYSE:NAPA) with a Buy and raises the price target from $25 to $28.

NAPA

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Citigroup Maintains Neutral on LegalZoom.com, Lowers Price Target to $27

By vishwanath@benzinga.com
Today, 10:36 AM
Citigroup analyst Jason Bazinet maintains LegalZoom.com (NASDAQ:LZ) with a Neutral and lowers the price target from $40 to $27.

LZ

Posts navigation

1 2 … 82 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service